抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Plozalizumab
All
TD-HW392016_1.jpg
- Catalog： TD-HW392016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： MLN-1202,anti-CCR2,hu1D9,CAS:1610761-46-0
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Plozalizumab
| Catalog No. | TD-HW392016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | CCR2, CC-CKR-2, C-C chemokine receptor type 2, CCR-2, C-C CKR-2, MCP-1-R, CMKBR2, CD192, Monocyte chemoattractant protein 1 receptor |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P41597 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | MLN-1202,anti-CCR2,hu1D9,CAS:1610761-46-0 |
| Background | Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SDS-PAGE for Research Grade Plozalizumab. |